摘要:
In order to provide a low molecular weight compound that has p38MAPK inhibitory activity and the accompanying TNFα production suppression activity and that has a favorable pharmacokinetic profile as a pharmaceutical and decreased hepatotoxicity, and to provide a pharmaceutical application of same, disclosed is a 2,3-dihydro-1H-indene-2-yl urea derivative represented below, a pharmacologically acceptable salt thereof, and a therapeutic agent or preventative agent that contains same as an active ingredient and that is for allergic dermatitis, inflammatory bowel disease, and pain.
摘要:
Disclosed is a novel cell membrane-permeable peptide which can transport a protein into a cell and/or a nucleus with a higher frequency than that in a conventional cell membrane-permeable peptide. Also disclosed is a pharmaceutical comprising the peptide.
摘要:
The present invention relates to novel crystal form of sunitinib malate, to processes for its preparation and to pharmaceutical compositions containing it.
摘要:
Self-microemulsifying drug delivery systems and microemulsions used to enhance the solubility of pharmaceutical ingredients comprising a polyoxyethylene sorbitan fatty acid ester emulsifier; a fatty acid ester co-emulsifier and an oil.